2-methoxy-6-phenylphenol | 222628-11-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-methoxy-6-phenylphenol
• 英文别名: 2-Methoxy-6-phenyl-phenol
• CAS: 222628-11-7
• 化学式: C₁₃H₁₂O₂
• 分子量: 200.237
• InChiKey: KORJLRWPBJDLNV-UHFFFAOYSA-N

物化性质

• 沸点：
  314.6±22.0 °C(Predicted)
• 密度：
  1.130±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-methoxy-6-phenylphenol 在 sodium hydroxide 、 四丁基溴化铵 作用下， 以 二氯甲烷 、 异丁醇 为溶剂， 反应 25.0h， 生成 (R)-2-[((2-(2-methoxy-6-phenylphenoxy)ethyl)amino)methyl]-1,4-benzodioxane
  参考文献：
  名称：

  WB4101-Related Compounds:  New, Subtype-Selective α₁-Adrenoreceptor Antagonists (or Inverse Agonists?)

  摘要：

  Our previous structure-affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues ( compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known alpha(1)-adrenoceptor (alpha(1)-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for alpha(1)-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5-7, respectively) and of a double- modified WB4101 derivative ( 8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA(2) 10.68) and moderately selective alpha(1D)-AR antagonist and the hybrid (S)-8 is a potent (pA(2) 7.98) and highly selective alpha(1A)-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.

  DOI：

  10.1021/jm060358r
• 作为产物：
  描述：

  2,3-dimethoxybiphenyl 在 磷酸 作用下， 以 1,4-二氧六环 、 水 为溶剂， 生成 2-methoxy-6-phenylphenol
  参考文献：
  名称：

  Biphenyl-5-alkanoic acid derivatives and use thereof

  摘要：

  由一般式I或其盐所代表的化合物，其中n是2或3的整数；R代表具有4个或4个碳原子的直链或支链饱和烷基基团，环戊基团，环己基团或类似物；Y代表羟基或氨基团；A代表氢原子，羟基，甲氧基，硝基团或类似物；Q代表氢原子或羟基或甲氧基团。它们可以配制成药物组合物，作为与IgE产生抑制剂或IgE抗体相关的过敏疾病的预防或治疗药剂。

  公开号：

  US06376546B1

文献信息

• [EN] DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS<br/>[FR] DÉRIVÉS DE TRIAZOLOPYRIDAZINES 6-SUBSTITUÉES EN TANT QU'AGONISTES DE REV-ERB
  申请人：GENFIT

  公开号：WO2013045519A1

  公开（公告）日：2013-04-04

  The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.

  本发明提供了新颖的激动Rev-Erb的6-取代[1,2,4]三唑并[4,3-b]吡啶嗪化合物。这些化合物以及包含它们的药物组合物是治疗任何激活Rev-Erb具有治疗效果的疾病的合适手段，例如在炎症和昼夜节律相关疾病或心脏代谢疾病中。
• Iron in the Service of Chromium:  The <i>ortho</i>-Benzannulation of <i>trans</i>,<i>trans</i>-Dienyl Fischer Carbene Complexes
  作者：Yiqian Lian、William D. Wulff

  DOI：10.1021/ja0540268

  日期：2005.12.1

  from dienyl chromium carbene complexes is a known process (ortho-benzannulation) that only occurs with certain cis,trans-dienyl complexes. Control experiments show that trans,trans-dienyl chromium carbene complexes do not undergo conversion to 2-alkoxyphenols in the absence of an iron source. The process most likely occurs either via coordination of the dienyl unit in the chromium carbene complex to

  卡宾碳上具有反式，反式二烯基取代基的铬费休卡宾配合物将与九羰基二铁反应，以优异的产率得到 2-烷氧基环六-2,4-二烯酮三羰基铁配合物和/或 2-烷氧基苯酚。在硅胶或碱的存在下，环己二烯酮络合物将遭受铁的损失和芳构化，得到2-烷氧基苯酚。从二烯基铬卡宾配合物形成 2-烷氧基苯酚是一种已知的过程（邻苯苄基化），仅在某些顺式，反式二烯基配合物中发生。对照实验表明，在没有铁源的情况下，反式，反式二烯基铬卡宾配合物不会转化为 2-烷氧基苯酚。
• BISPHENOL COMPOUND AND AROMATIC POLYCARBONATE
  申请人：Honshu Chemical Industry Co., Ltd.

  公开号：US20190047954A1

  公开（公告）日：2019-02-14

  The present invention addresses the problem of providing; a novel bisphenol compound having an indoline skeleton; and a novel aromatic polycarbonate which uses this bisphenol compound as a starting material dihydroxy compound. The above-described problem is able to be solved by an aromatic polycarbonate that contains a repeating unit represented by general formula (2).

  本发明解决了提供具有吲哚骨架的新型双酚化合物和使用该双酚化合物作为起始材料二羟基化合物的新型芳香族聚碳酸酯的问题。上述问题可以通过含有通式（2）所表示的重复单元的芳香族聚碳酸酯来解决。
• Catalyst Compounds and Use Thereof
  申请人：GIESBRECHT Garth R.

  公开号：US20110098431A1

  公开（公告）日：2011-04-28

  This invention relates to Group 4 dialkyl compounds supported by a pyridyl-amido-aryl (“PAA”), an anisole-amido-aryl (“AAA”), a phenoxy-amido-pyridyl (“PAPY”), an anisole-amido-phenoxy (“AAP”) or a anisole-amido-phenoxy (“AAP”) tridentate ligand. Such compounds can polymerize olefins, such as ethylene.

  本发明涉及由吡啶基氨基芳基（“PAA”）、甲氧基基氨基芳基（“AAA”）、苯氧基氨基吡啶基（“PAPY”）、甲氧基基氨基苯氧基（“AAP”）或甲氧基基苯氧基（“AAP”）三齿配体支撑的第四族二烷基化合物。这些化合物可以聚合烯烃，例如乙烯。
• DERIVATIVES OF 6-SUBSTITUTED TRIAZOLOPYRIDAZINES AS REV-ERB AGONISTS
  申请人：GENFIT

  公开号：US20150038503A1

  公开（公告）日：2015-02-05

  The present invention provides novel 6-substituted [1,2,4]triazolo[4,3-b]pyridazines that are agonists of Rev-Erb. These compounds, and pharmaceutical compositions comprising the same, are suitable means for treating any disease wherein the activation of Rev-Erb has therapeutic effects, for instance in inflammatory and circadian rhythm-related disorders or cardiometabolic diseases.

  本发明提供了新型的6-取代[1,2,4]三唑并[4,3-b]吡啶嗪，这些化合物是Rev-Erb激动剂。这些化合物及其含有的药物组合物是治疗任何需要Rev-Erb激活具有治疗效果的疾病的适当手段，例如炎症和昼夜节律相关疾病或心脏代谢疾病。